(Q36095647)

12 August 2017

1 reference

title

Inflammation--a new therapeutic target in pneumonia (English)

1 reference

12 August 2017

1 reference

Mario Cazzola

1

1 reference

12 August 2017

Maria Gabriella Matera

series ordinal

2

1 reference

12 August 2017

Gabriella Pezzuto

series ordinal

3

1 reference

12 August 2017

publication date

1 March 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

72

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

117-126

1 reference

Acute stress decreases inflammation at the site of infection. A role for nitric oxide

12 August 2017

cites work

1 reference

State-of-the-art therapy for severe sepsis and multisystem organ dysfunction

21 January 2018

1 reference

Points of control in inflammation

21 January 2018

1 reference

Host innate defenses in the lung: the role of cytokines

21 January 2018

1 reference

Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing?

21 January 2018

1 reference

Molecular basis of the cell specificity of cytokine action

21 January 2018

1 reference

Binding of bacterial peptidoglycan to CD14.

21 January 2018

1 reference

Anti-inflammatory cytokine profile and mortality in febrile patients

21 January 2018

1 reference

21 January 2018

Immunotherapy of sepsis

1 reference

Cytokines as targets of immunotherapy in bacterial pneumonia.

21 January 2018

1 reference

The biology of chemokines and their receptors

21 January 2018

1 reference

Streptococcus pneumoniae strain-dependent lung inflammatory responses in a murine model of pneumococcal pneumonia

21 January 2018

1 reference

Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls

21 January 2018

1 reference

Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose

21 January 2018

1 reference

Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial

21 January 2018

1 reference

Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study

21 January 2018

1 reference

Novel approaches to the treatment of pneumonia.

21 January 2018

1 reference

Alternative and/or integrative therapies for pneumonia under development.

21 January 2018

1 reference

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy

21 January 2018

1 reference

Novel nonantibiotic therapies for pneumonia: cytokines and host defense

21 January 2018

1 reference

Intrapulmonary tumor necrosis factor gene therapy increases bacterial clearance and survival in murine gram-negative pneumonia

21 January 2018

1 reference

Cytokine therapeutics for infectious diseases

21 January 2018

1 reference

Transient transgenic expression of gamma interferon promotes Legionella pneumophila clearance in immunocompetent hosts

21 January 2018

1 reference

Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol

21 January 2018

1 reference

GM-CSF restores innate, but not adaptive, immune responses in glucocorticoid-immunosuppressed human blood in vitro

21 January 2018

1 reference

Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis

21 January 2018

1 reference

G-CSF application in patients with severe bacterial pneumonia increases IL-10 expression in neutrophils.

21 January 2018

1 reference

Granulocyte colony-stimulating factor enhances host defenses against bacterial pneumonia following peritonitis in nonneutropenic rats

21 January 2018

1 reference

Lipopolysaccharide as a target for the development of novel therapeutics in gram-negative bacteria

21 January 2018

1 reference

Bacterial lipopolysaccharides and innate immunity

21 January 2018

1 reference

Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages

21 January 2018

1 reference

Novel therapies for sepsis: antiendotoxin therapies

21 January 2018

1 reference

MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4

21 January 2018

1 reference

Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14.

21 January 2018

1 reference

ML -- a conserved domain involved in innate immunity and lipid metabolism

21 January 2018

1 reference

Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction

21 January 2018

1 reference

Targeting metalloenzymes: a strategy that works

21 January 2018

1 reference

Inhibition of the antibacterial target UDP-(3-O-acyl)-N-acetylglucosamine deacetylase (LpxC): isoxazoline zinc amidase inhibitors bearing diverse metal binding groups

21 January 2018

1 reference

Antibacterial activities and characterization of novel inhibitors of LpxC.

21 January 2018

1 reference

High-throughput catch-and-release synthesis of oxazoline hydroxamates. Structure-activity relationships in novel inhibitors of Escherichia coli LpxC: in vitro enzyme inhibition and antibacterial properties

21 January 2018

1 reference

Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis

21 January 2018

1 reference

Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia

21 January 2018

1 reference

LPS binding protein does not participate in the pharmacokinetics of E5564.

21 January 2018

1 reference

Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist

21 January 2018

1 reference

Safety, pharmacokinetics, pharmacodynamics, and plasma lipoprotein distribution of eritoran (E5564) during continuous intravenous infusion into healthy volunteers

21 January 2018

1 reference

Stimulation of Toll-like receptor 4 by lipopolysaccharide during cellular invasion by live Salmonella typhimurium is a critical but not exclusive event leading to macrophage responses

21 January 2018

1 reference

Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases.

21 January 2018

1 reference

A Limulus anti-LPS factor-derived peptide modulates cytokine gene expression and promotes resolution of bacterial acute infection in mice

21 January 2018

1 reference

Differential regulation of Th1/Th2 in relevant tissues for sepsis pathogenesis with a Limulus anti-LPS factor-derived peptide increases survival in Gram-positive sepsis.

21 January 2018

1 reference

Cyclic antimicrobial peptides based on Limulus anti-lipopolysaccharide factor for neutralization of lipopolysaccharide

21 January 2018

1 reference

Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-alpha production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock

21 January 2018

1 reference

Role of the bactericidal/permeability-increasing protein in host defence.

21 January 2018

1 reference

Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia

21 January 2018

1 reference

Therapeutic potential of the bactericidal/permeability-increasing protein

21 January 2018

1 reference

A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo

21 January 2018

1 reference

Lung inflammation as a therapeutic target in cystic fibrosis.

21 January 2018

1 reference

The Problems and Challenges of Immunotherapy in Sepsis*

21 January 2018

1 reference

IFNs and STATs in innate immunity to microorganisms

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000084039

1 reference

12 August 2017

1 reference